Biofrontera Inc. (BFRI)
Biofrontera Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Woburn, MA, US. The stock last traded at $1.22, up 0.83% on the session, giving a market capitalisation of $15.6M. On trailing twelve-month figures it carries a trailing P/E of -1.09, a net margin of -25.7%. Its beta of 0.80 implies it has historically moved less than the broad market.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Biofrontera Inc. is most often compared with the following Healthcare names: